Shou-Man Wang
Overview
Explore the profile of Shou-Man Wang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
106
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yuan J, Wang S, Guo L
Heliyon
. 2023 Feb;
9(2):e13294.
PMID: 36755606
Purpose: The purpose of this study was to investigate the correlation between S100 calcium binding protein A9 (S100A9), tumour glycolysis and tumour infiltrating lymphocytes (TIL) in human epidermal growth factor...
2.
Yuan J, Xiao Z, Wang S, Guo L
Gland Surg
. 2022 Mar;
11(2):451-465.
PMID: 35284307
Background: This study sought to estimate the prognostic effect of intratumoral heterogeneity (ITH) and Yes-associated protein 1 (YAP1) intensity in human epidermal growth factor receptor 2 (HER2) positive breast cancer...
3.
Yuan J, Zhang K, Wang S, Guo L
Gland Surg
. 2021 Nov;
10(9):2799-2814.
PMID: 34733729
Background: To evaluate the association of potential YAP1/MMP7/CXCL16 axis and tumor infiltrating lymphocytes (TILs) related chemo-response in triple-negative breast cancer (TNBC) patients. Methods: We estimated the messenger RNA (mRNA) expression...
4.
Wang S, Pang J, Zhang K, Zhou Z, Chen F
Mol Ther Oncolytics
. 2021 Apr;
21:62-73.
PMID: 33869743
Triple-negative breast cancer (TNBC) is a highly invasive subtype of breast cancer. This study investigated the molecular mechanism and influences of MIR503HG, miR-224-5p, and homeobox A9 (HOXA9) on TNBC cell...
5.
Chen F, Zhou Z, Zhang K, Pang J, Wang S
Cancer Cell Int
. 2020 Oct;
20:508.
PMID: 33088216
Background: As an aggressive subtype of breast cancer with a high risk of recurrence, triple-negative breast cancer (TNBC) lacks available treatment targets. LncRNA MIR100HG promotes cell proliferation in TNBC. However,...
6.
Xu Y, Deng J, Wang L, Zhang H, Tang L, Huang Y, et al.
DNA Cell Biol
. 2020 May;
39(7):1205-1227.
PMID: 32456464
Breast cancer (BC) is the most malignant tumor in women. The molecular mechanisms underlying tumorigenesis still need to be further elucidated. It is necessary to investigate novel candidate genes involved...
7.
Chen F, Wang H, Li H, Hu X, Dai X, Wang S, et al.
Technol Cancer Res Treat
. 2019 Feb;
17:1533033818819841.
PMID: 30799775
Objective: The aim of the study was to estimate breast cancer risk conferred by individual single-nucleotide polymorphisms of breast cancer susceptibility genes. Methods: We analyzed the 48 tagging single-nucleotide polymorphisms...
8.
Yuan J, Wang S, Tang L, Mao J, Wu Y, Hai J, et al.
Breast Cancer Res Treat
. 2015 May;
151(2):405-13.
PMID: 25956059
To investigate the relationship between chemotherapy dose intensity and therapy efficacy of different molecular subtypes. Clinical and pathological features of the patients with breast cancer were retreived from the hospital...
9.
Chen F, Ou H, Wang S, Wu Y, Yan G, Tang L
Ther Clin Risk Manag
. 2013 Apr;
9:131-7.
PMID: 23576872
Background: Several studies have shown a positive association between body mass index (BMI) and the development of hormone receptor-positive breast cancer in postmenopausal women; however, the associations between BMI groups...
10.
Tang L, Chen F, Wang H, Hu X, Dai X, Mao J, et al.
Cancer Epidemiol
. 2013 Jan;
37(3):311-7.
PMID: 23357080
Background: Ten genes are associated with increased susceptibility to inherited breast cancer have also been associated with population breast cancer risk, and all are involved directly or indirectly in the...